Literature DB >> 17725516

Seizures beget seizures: the quest for GABA as a key player.

Yehezkel Ben-Ari1.   

Abstract

Synapses mediated by gamma-aminobutyric acid (GABA) A receptors are notoriously altered during periods of enhanced activity. Since a loss of inhibitory tone is a basic cause of seizures and epilepsies, it is important to determine the underlying mechanisms and the way this could be alleviated or at least reduced. Alterations of the intracellular content of chloride are thought to be a major player in the sequence of events that follow episodes of hyperactivity. In this review, I discuss these mechanisms both in the adult and developing brain, relying on studies in which chloride and GABAergic currents were measured by electrophysiological and imaging techniques. The main conclusion is that in adult systems, status epilepticus induces a complete re-organization of the networks, with cell death, axonal growth, and glutamatergic neosynapse formation leading to an increased glutamatergic drive. This, in turn, will decrease the threshold of seizure generation and thus contribute to seizure generation. In contrast, GABAergic synapses are not readily "plastic" as the lost interneurones and synapses are not replaced. Somatostatin-positive 0-LM Interneurons that innervate the dendrites of the principal cells in the hippocampus degenerate selectively, leading to a loss of the inhibitory drive in the dendrites, whereas somatic projecting basket cells and somatic inhibitory drives are relatively spared. This imbalance leads to a reduction of the inhibitory strength that is necessary but not sufficient to generate ongoing seizures. An additional important factor is the persistent increase of the intracellular chloride concentration that leads to a long-lasting shift in the depolarizing direction of the actions of GABA that will also contribute to seizure generation. In the developing brain, a major source of seizure generation is the depolarizing and often excitatory actions of GABA due to a higher intracellular chloride concentration ([Cl-]I) in immature neurons, a property that has been confirmed in all developing systems and animal species studied. As a consequence, immature GABAergic synapses will excite targets and facilitate the emergence of seizures, in keeping with the well-known higher incidence of seizures in the developing brain. Using a unique preparation with two intact hippocampi placed in a three-compartment chamber in vitro, we have provided direct evidence that seizures beget seizures and that GABA signaling plays a central role in this phenomenon. Indeed, recurrent seizures triggered in one hippocampus by a convulsive agent propagate to the other hippocampus and transform the naive hippocampus into one that generates seizures once disconnected from the other hippocampus. This transformation is conditioned by the occurrence during the seizures of high-frequency oscillations (40 Hz and above). Interestingly, these oscillations are only produced when N-methyl-D-aspartate (NMDA-) and GABA receptors are operative and not blocked in the naïve hippocampus. Therefore, GABA-receptor antagonists are pro-convulsive in the developing brain but, in fact, anti-epileptic. This paradoxical conclusion has quite a few clinical implications that are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17725516     DOI: 10.1615/critrevneurobiol.v18.i1-2.140

Source DB:  PubMed          Journal:  Crit Rev Neurobiol        ISSN: 0892-0915


  32 in total

Review 1.  The contribution of GABAergic dysfunction to neurodevelopmental disorders.

Authors:  Kartik Ramamoorthi; Yingxi Lin
Journal:  Trends Mol Med       Date:  2011-04-21       Impact factor: 11.951

2.  Olig1 function is required to repress dlx1/2 and interneuron production in Mammalian brain.

Authors:  John C Silbereis; Hiroko Nobuta; Hui-Hsin Tsai; Vivi M Heine; Gabriel L McKinsey; Dimphna H Meijer; Mackenzie A Howard; Magda A Petryniak; Gregory B Potter; John A Alberta; Scott C Baraban; Charles D Stiles; John L R Rubenstein; David H Rowitch
Journal:  Neuron       Date:  2014-02-05       Impact factor: 17.173

3.  Inhibitory plasticity dictates the sign of plasticity at excitatory synapses.

Authors:  Lang Wang; Arianna Maffei
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

4.  STE20/SPS1-related proline/alanine-rich kinase is involved in plasticity of GABA signaling function in a mouse model of acquired epilepsy.

Authors:  Libai Yang; Xiaodong Cai; Jueqian Zhou; Shuda Chen; Yishu Chen; Ziyi Chen; Qian Wang; Ziyan Fang; Liemin Zhou
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

5.  Education of a child neurologist: developmental neuroscience relevant to child neurology.

Authors:  Michael V Johnston
Journal:  Semin Pediatr Neurol       Date:  2011-06       Impact factor: 1.636

6.  PAF-AH Catalytic Subunits Modulate the Wnt Pathway in Developing GABAergic Neurons.

Authors:  Idit Livnat; Danit Finkelshtein; Indraneel Ghosh; Hiroyuki Arai; Orly Reiner
Journal:  Front Cell Neurosci       Date:  2010-05-28       Impact factor: 5.505

Review 7.  GABA-ergic cell therapy for epilepsy: Advances, limitations and challenges.

Authors:  Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2015-12-31       Impact factor: 8.989

Review 8.  Molecular mechanisms of antiseizure drug activity at GABAA receptors.

Authors:  L John Greenfield
Journal:  Seizure       Date:  2013-05-14       Impact factor: 3.184

9.  Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy.

Authors:  Bharathi Hattiangady; Muddanna S Rao; Ashok K Shetty
Journal:  Exp Neurol       Date:  2008-05-15       Impact factor: 5.330

10.  Doublecortin-expressing cells persist in the associative cerebral cortex and amygdala in aged nonhuman primates.

Authors:  Xue-Mei Zhang; Yan Cai; Yaping Chu; Er-Yun Chen; Jia-Chun Feng; Xue-Gang Luo; Kun Xiong; Robert G Struble; Richard W Clough; Peter R Patrylo; Jeffrey H Kordower; Xiao-Xin Yan
Journal:  Front Neuroanat       Date:  2009-10-13       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.